...
首页> 外文期刊>The Journal of Nuclear Medicine >Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging
【24h】

Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging

机译:PET心肌灌注显像的18F标签氟烷基phosph阳离子与13N-NH3的比较

获取原文
           

摘要

Despite substantial advances in the diagnosis of cardiovascular disease, there is a need for 18F-labeled myocardial perfusion agents for the diagnosis of ischemic heart disease because current PET tracers for myocardial perfusion imaging have a short half-life that limits their widespread clinical use in PET. Thus, 18F-labeled fluoroalkylphosphonium derivatives (18F-FATPs), including (5-18F-fluoropentyl)triphenylphosphonium cation (18F-FPTP), (6-18F-fluorohexyl)triphenylphosphonium cation (18F-FHTP), and (2-(2-18F-fluoroethoxy)ethyl)triphenylphosphonium cation (18F-FETP), were synthesized. The myocardial extraction and image quality of the 18F-FATPs were compared with those of 13N-NH3 in rat models. Methods: The first-pass extraction fraction (EF) values of the 18F-FATPs (18F-FPTP, 18F-FHTP, 18F-FETP) and 13N-NH3 were measured in isolated rat hearts perfused with the Langendorff method (flow velocities, 0.5, 4.0, 8.0, and 16.0 mL/min). Normal and myocardial infarction rats were imaged with small-animal PET after intravenous injection of 37 MBq of 18F-FATPs and 13N-NH3. To determine pharmacokinetics, a region of interest was drawn around the heart, and timea€“activity curves of the 18F-FATPs and 13N-NH3 were generated to obtain the counts per pixel per second. Defect size was analyzed on the basis of polar map images of 18F-FATPs and 13N-NH3. Results: The EF values of 18F-FATPs and 13N-NH3 were comparable at low flow velocity (0.5 mL/min), whereas at higher flows EF values of 18F-FATPs were significantly higher than those of 13N-NH3 (4.0, 8.0, and 16.0 mL/min, P 0.05). Myocardium-to-liver ratios of 18F-FPTP, 18F-FHTP, 18F-FETP, and 13N-NH3 were 2.10 ?± 0.30, 4.36 ?± 0.20, 3.88 ?± 1.03, and 0.70 ?± 0.09, respectively, 10 min after injection, whereas myocardium-to-lung ratios were 5.00 ?± 0.25, 4.33 ?± 0.20, 7.98 ?± 1.23, and 2.26 ?± 0.14, respectively. Although 18F-FATPs and 13N-NH3 sharply delineated myocardial perfusion defects, defect size on the 13N-NH3 images was significantly smaller than on the 18F-FATP images soon after tracer injection (0a€“10 min, P = 0.027). Conclusion: 18F-FATPs exhibit higher EF values and more rapid clearance from the liver and lung than 13N-NH3 in normal rats, which led to excellent image quality in a rat model of coronary occlusion. Therefore, 18F-FATPs are promising new PET radiopharmaceuticals for myocardial perfusion imaging.
机译:尽管在心血管疾病的诊断方面取得了重大进展,但仍需要18F标记的心肌灌注剂来诊断缺血性心脏病,因为当前用于心肌灌注显像的PET示踪剂的半衰期短,限制了它们在PET中的广泛临床应用。因此,18F标记的氟代烷基alkyl衍生物(18F-FATP),包括(5-18F-氟戊基)三苯基phosph阳离子(18F-FPTP),(6-18F-氟己基)三苯基phosph阳离子(18F-FHTP)和(2-(2合成了-18F-氟乙氧基)乙基)三苯基phosph阳离子(18F-FETP)。在大鼠模型中比较了18F-FATP与13N-NH3的心肌提取和图像质量。方法:在用Langendorff方法灌注的离体大鼠心脏中测量18F-FATP(18F-FPTP,18F-FHTP,18F-FETP)和13N-NH3的首过提取分数(EF)值(流速0.5) ,4.0、8.0和16.0 mL / min)。静脉注射37 MB的18F-FATP和13N-NH3后,用小动物PET对正常和心肌梗死大鼠进行成像。为了确定药代动力学,在心脏周围绘制了一个感兴趣的区域,并生成了18F-FATP和13N-NH3的时间活性曲线,以获得每像素每秒的计数。根据18F-FATP和13N-NH3的极谱图图像分析缺陷大小。结果:在低流速(0.5 mL / min)下,18F-FATP和13N-NH3的EF值可比,而在较高流速下,18F-FATP的EF值显着高于13N-NH3(4.0、8.0,和16.0 mL / min,P <0.05)。在10分钟后的18F-FPTP,18F-FHTP,18F-FETP和13N-NH3的心肌-肝脏比率分别为2.10±0.30、4.36±0.20、3.88±1.03和0.70±±0.09。注射时,心肌与肺的比例分别为5.00±0.25、4.33±0.20、7.98±1.23和2.26±0.14。尽管18F-FATP和13N-NH3清晰地描绘出了心肌灌注缺陷,但示踪剂注射后不久,13N-NH3图像上的缺陷大小显着小于18F-FATP图像上的缺陷大小(0a-10分钟,P = 0.027)。结论:在正常大鼠中,18F-FATP比13N-NH3表现出更高的EF值和更快的肝,肺清除率,从而在冠状动脉闭塞模型中产生了出色的图像质量。因此,18 F-FATP是有前途的用于心肌灌注显像的新型PET放射性药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号